TK CHEMICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,587 KRW | +0.25% |
|
+3.52% | -10.89% |
| 2021 | TK Chemical Corporation(KOSDAQ:A104480) added to S&P Global BMI Index | CI |
| 2019 | E&H Co., Ltd. announced that it has received KRW 14 billion in funding from TK Chemical Corporation | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Capitalization 1 | 251,780 | 190,976 | 218,997 | 516,286 |
| Enterprise Value (EV) 1 | 489,247 | 468,442 | 472,805 | 730,612 |
| P/E ratio | 8.44 x | 20.1 x | -162 x | 1.45 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.32 x | 0.31 x | 0.51 x | 0.74 x |
| EV / Revenue | 0.62 x | 0.75 x | 1.1 x | 1.05 x |
| EV / EBITDA | 7.49 x | 22.5 x | -52.3 x | 9.65 x |
| EV / FCF | - | -20,818,596 x | 13,966,828 x | 40,583,791 x |
| FCF Yield | - | -0% | 0% | 0% |
| Price to Book | 0.92 x | 0.7 x | 0.82 x | 0.77 x |
| Nbr of stocks (in thousands) | 90,895 | 86,219 | 86,219 | 90,895 |
| Reference price 2 | 2,770 | 2,215 | 2,540 | 5,680 |
| Announcement Date | 3/16/20 | 3/16/20 | 3/23/21 | 3/23/22 |
1KRW in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net sales 1 | 789,034 | 620,804 | 429,303 | 693,903 |
| EBITDA 1 | 65,292 | 20,850 | -9,035 | 75,696 |
| EBIT 1 | 54,544 | 9,636 | -21,006 | 66,516 |
| Operating Margin | 6.91% | 1.55% | -4.89% | 9.59% |
| Earnings before Tax (EBT) 1 | 38,006 | 10,572 | 961.3 | 420,952 |
| Net income 1 | 28,284 | 9,492 | -1,355 | 350,833 |
| Net margin | 3.58% | 1.53% | -0.32% | 50.56% |
| EPS 2 | 328.1 | 110.1 | -15.72 | 3,921 |
| Free Cash Flow | - | -22,501 | 33,852 | 18,003 |
| FCF margin | - | -3.62% | 7.89% | 2.59% |
| FCF Conversion (EBITDA) | - | - | - | 23.78% |
| FCF Conversion (Net income) | - | - | - | 5.13% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/16/20 | 3/16/20 | 3/23/21 | 3/23/22 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net Debt 1 | 237,467 | 277,466 | 253,807 | 214,326 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.637 x | 13.31 x | -28.09 x | 2.831 x |
| Free Cash Flow | - | -22,501 | 33,852 | 18,003 |
| ROE (net income / shareholders' equity) | - | 3.57% | -0.5% | 75% |
| ROA (Net income/ Total Assets) | - | 0.88% | -1.93% | 4.55% |
| Assets 1 | - | 1,074,478 | 70,157 | 7,711,965 |
| Book Value Per Share 2 | 3,011 | 3,151 | 3,099 | 7,347 |
| Cash Flow per Share 2 | 80.80 | 100.0 | 188.0 | 138.0 |
| Capex 1 | 4,878 | 12,568 | 5,452 | 3,758 |
| Capex / Sales | 0.62% | 2.02% | 1.27% | 0.54% |
| Announcement Date | 3/16/20 | 3/16/20 | 3/23/21 | 3/23/22 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.89% | 105M | |
| +21.36% | 6.6B | |
| +13.96% | 1.53B | |
| -7.56% | 1.28B | |
| +18.07% | 1.18B | |
| +10.93% | 1.08B | |
| +24.05% | 1.02B | |
| +6.04% | 762M | |
| +0.97% | 607M | |
| -17.65% | 561M |
- Stock Market
- Equities
- A104480 Stock
- Financials TK Chemical Corporation
